To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
Based on the bill's title, this legislation would amend the Federal Food, Drug, and Cosmetic Act to make permanent the Secretary of Health and Human Services' authority to award priority review vouchers for rare pediatric disease products. Priority review vouchers expedite the FDA's review of drug applications, potentially reducing the time to market for treatments targeting rare diseases affecting children. The bill would extend what appears to be a temporary or expiring authority on a permanent basis.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.